我武生物: 2025年半年度业绩预告

Performance Forecast - The company expects a net profit attributable to shareholders of 170 million to 185 million yuan, representing a year-on-year increase of 13.92% compared to 149.23 million yuan in the same period last year [1] - The net profit after deducting non-recurring gains and losses is projected to be between 165.5 million and 180.5 million yuan, reflecting a year-on-year growth of 16.96% to 27.56% compared to 141.50 million yuan last year [1] Sales Performance - The sales revenue from dust mite drops reached 454.66 million yuan, an increase of 10.51% year-on-year [1] - The sales revenue from Artemisia pollen sublingual drops was 21.02 million yuan, showing a significant growth of 71.37% compared to the previous year [1] - The sales revenue from skin prick solution was 6.33 million yuan, marking a substantial increase of 104.38% year-on-year [1] - The rapid growth in sales of Artemisia pollen sublingual drops and skin prick solution is attributed to the company's increased marketing efforts for these products [1]